AOD-9604 in Merzen — Fat Loss Peptide Research Guide
AOD-9604 research guide for Merzen. HGH fragment studied for fat metabolism — covers mechanism, purity standards, COA verification, and how to source AOD-9604.
Most researchers searching for AOD-9604 in Merzen soon discover that local retail options are nearly impossible to find. What this means for Merzen researchers is that physical proximity is irrelevant compared to your ability to evaluate vendor quality — and those quality checks are within reach of all serious researchers. What genuinely separates top AOD-9604 vendors is complete batch-specific analytical documentation: HPLC for purity, mass spec for peptide identity confirmation, and endotoxin testing for contamination assurance. What follows is a practical research guide built specifically around AOD-9604, covering everything a Merzen researcher needs to evaluate quality systematically.
The Science Behind AOD-9604
CJC-1295 with DAC (Drug Affinity Complex) is a GHRH analogue with an extended half-life achieved through DAC technology that enables covalent binding to albumin. This modification extends the half-life from minutes (for native GHRH) to approximately 6-8 days, creating a sustained elevation in basal GH levels rather than the pulsatile pattern produced by GHRP compounds. This pharmacokinetic distinction is significant for research design: AOD-9604 based on CJC-1295 with DAC produces a different GH secretion pattern than GHRP compounds, with different downstream effects on IGF-1 and protein synthesis. Researchers in Merzen comparing compounds in this class should account for these pharmacokinetic differences in their experimental design.
How to Source AOD-9604 — Vendor Guide
Before assessing any particular supplier, understand what genuine quality documentation contains — so you can identify whether a supplier meets the standard. The HPLC chromatogram is the most important document in the COA: it should show a clear dominant peak representing AOD-9604, with minimal secondary peaks representing impurities — purity should be stated as ≥98%. Positive vendor signals beyond COA quality: documented vendor history spanning multiple years, responsive technical support who understand testing methodology, and shipping with desiccant and appropriate cold protection. Bacteriostatic water is the appropriate reconstitution medium for AOD-9604 — it contains 0.9% benzyl alcohol that prevents microbial contamination and extends reconstituted shelf life to 4 weeks when kept refrigerated.
Order AOD-9604 — ships to Merzen
COA-verified · International tracking · Research grade
All use of AOD-9604 in Merzen or anywhere must be research use only — this compound is not approved for therapeutic human application, and all handling should comply with standard research safety practices. Storage requirements for AOD-9604: lyophilised powder at freezer temperature, reconstituted solution refrigerated at 2-8°C and finished within 30 days of reconstitution; reconstitute only with bacteriostatic water. Quality AOD-9604 sourcing directly determines safety outcomes — bacterial endotoxin contamination, incorrect identity, and breakdown products are all safety issues that rigorous vendor evaluation eliminates. Researchers using AOD-9604 alongside other research compounds should check the research literature for any reported interactions before beginning combination research.
Frequently Asked Questions
How does AOD-9604 differ from growth hormone?
AOD-9604 contains only the fat-metabolism-relevant fragment of growth hormone (the C-terminal region) without the IGF-1-stimulating N-terminal domain. This means it targets fat cells' beta-adrenergic receptors for lipolytic effects without producing the anabolic IGF-1 signaling associated with full-length GH.
What is the clinical trial history of AOD-9604?
AOD-9604 has undergone multiple Phase II clinical trials for obesity treatment by Metabolic Pharmaceuticals in Australia. The trials showed safety and tolerability but mixed efficacy results for weight loss. It holds GRAS (Generally Recognized As Safe) status from the FDA for food use, which is unusual for research peptides.
What is AOD-9604?
AOD-9604 is a synthetic peptide analogue of the C-terminal fragment of human growth hormone (amino acids 177-191), with an additional tyrosine residue at the N-terminus. It has been studied for fat metabolism effects, specifically lipolysis stimulation and lipogenesis inhibition, without the IGF-1-stimulating effects of full-length GH. It has undergone clinical trials for obesity treatment.
